ATE401873T1 - Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten - Google Patents

Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten

Info

Publication number
ATE401873T1
ATE401873T1 AT03704764T AT03704764T ATE401873T1 AT E401873 T1 ATE401873 T1 AT E401873T1 AT 03704764 T AT03704764 T AT 03704764T AT 03704764 T AT03704764 T AT 03704764T AT E401873 T1 ATE401873 T1 AT E401873T1
Authority
AT
Austria
Prior art keywords
treatment
spermidine derivatives
diseases
chronic
chronic neurodegenative
Prior art date
Application number
AT03704764T
Other languages
English (en)
Inventor
Barclay Morrison Iii
Ashley Pringle
Lars Sundstrom
Ernst Wuelfert
Original Assignee
Univ Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southampton filed Critical Univ Southampton
Application granted granted Critical
Publication of ATE401873T1 publication Critical patent/ATE401873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03704764T 2002-02-05 2003-02-05 Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten ATE401873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0202645.8A GB0202645D0 (en) 2002-02-05 2002-02-05 Treatment of chronic neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ATE401873T1 true ATE401873T1 (de) 2008-08-15

Family

ID=9930436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03704764T ATE401873T1 (de) 2002-02-05 2003-02-05 Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten

Country Status (9)

Country Link
US (1) US20050124554A1 (de)
EP (1) EP1471901B1 (de)
JP (1) JP2005526717A (de)
AT (1) ATE401873T1 (de)
AU (1) AU2003207024A1 (de)
DE (1) DE60322343D1 (de)
ES (1) ES2309300T3 (de)
GB (1) GB0202645D0 (de)
WO (1) WO2003066037A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211743A1 (en) * 2005-03-21 2006-09-21 Children's Medical Center Corporation 3-Pyridinecarboxamide reduces nerve degeneration
JPWO2008105441A1 (ja) * 2007-02-27 2010-06-03 味の素株式会社 リン吸収抑制活性を有するポリアミノ酸化合物及びリン吸収抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242947A (en) * 1988-02-10 1993-09-07 New York University Use of polyamines as ionic-channel regulating agents
WO1991000853A1 (en) * 1989-07-03 1991-01-24 New York University Use of polyamines as ionic-channel regulating agents
WO1999003823A2 (en) * 1997-07-15 1999-01-28 Oridigm Corporation Novel polyamine analogues as therapeutic and diagnostic agents
GB9726569D0 (en) * 1997-12-16 1998-02-11 Univ Southampton Neuroprotective agents

Also Published As

Publication number Publication date
DE60322343D1 (de) 2008-09-04
ES2309300T3 (es) 2008-12-16
GB0202645D0 (en) 2002-03-20
EP1471901B1 (de) 2008-07-23
JP2005526717A (ja) 2005-09-08
WO2003066037A1 (en) 2003-08-14
AU2003207024A1 (en) 2003-09-02
US20050124554A1 (en) 2005-06-09
EP1471901A1 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
GB0318447D0 (en) Therapeutic agents
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
DK1480961T3 (da) Glutaminylbaserede DPIV-inhibitorer
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
MY142988A (en) Novel aminobenzophenone compounds
EA200401114A2 (ru) Замещённые гидроксиэтиламины
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
WO2010075280A3 (en) Coumarin-based compounds for the treatment of alzheimer's disease and cancer
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
SE0002739D0 (sv) New use
BRPI0415355A (pt) triarilimidazóis
ATE401873T1 (de) Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten
ATE360415T1 (de) Behandlung von dyskinesie
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
ATE431348T1 (de) Thiaepothilone zur behandlung von krebserkrankungen
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.
EA200500382A1 (ru) Соединения тиазола для лечения нейродегенеративных расстройств
TW200505836A (en) Cyclic sulfonamides for inhibition of gamma-secretase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties